Waters Corporation (WAT) Income Statement

The 2026Q2 revenue of $1.6B represents a dramatic acceleration from the 6.8% growth seen in 2025Q4, but the sequential jump from $1.3B in 2026Q1 indicates a one-time event rather than organic momentum. Prior quarters showed consistent 4-9% growth, so investors should question the sustainability of this spike. The sharp increase may reflect a large contract or acquisition, but without segment detail, the durability of this growth rate is uncertain.

The gross margin decline is stark, with 2026Q2 at 44.6% versus a stable 58-60% range throughout 2024 and 2025. This compression likely stems from the revenue surge, possibly indicating lower-margin product sales or inventory write-downs. If this margin level persists, it would erode the company's competitive position relative to peers like Agilent (52.4% gross margin). The 2026Q1 margin of 47.0% also suggests the deterioration is not isolated to one quarter.

Despite a 72% sequential revenue increase from 2026Q1 to 2026Q2, operating income deteriorated from -$47M to -$86M, implying that variable costs and operating expenses are growing faster than revenue. SG&A jumped from $394M to $405M, but the gross profit increase of $139M was more than offset by a $211M rise in total operating expenses. This suggests a structural inefficiency in cost management, possibly due to integration costs or one-time charges, which warrants close monitoring.

The COGS-to-revenue ratio jumped from 40.2% to 55.4% in just two quarters, which is a dramatic shift and suggests that the incremental revenue is being generated at a much lower margin. This could be due to product mix, expedited manufacturing costs, or supply chain disruptions. Meanwhile, R&D and SG&A expenses have also increased, but the primary cost pressure is in COGS, which is unusual for a diagnostics company and may indicate a temporary issue.

This quarter is the most significant in the provided data, as it breaks the historical pattern of stable profitability. The revenue surge to $1.6B is unprecedented, but the simultaneous collapse in margins and profitability suggests a strategic pivot or a major one-time event. The lasting impact will depend on whether the company can restore margins to historical levels, but the current data indicates a structural change that investors must reassess.